Baxter International (BAX) Shares are Down -1.32%

Baxter International (BAX) has risen sharply, recording gains of 3.52% in the past 4 weeks. However, the stock has corrected -1.32% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 3.12% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

Baxter International Inc. is up 12.06% in the last 3-month period. Year-to-Date the stock performance stands at 26.43%. The stock has recorded a 20-day Moving Average of 0.23% and the 50-Day Moving Average is 3.25%.


Baxter International (NYSE:BAX): The stock opened at $47.87 on Friday but the bulls could not build on the opening and the stock topped out at $48.06 for the day. The stock traded down to $47.59 during the day, due to lack of any buying support eventually closed down at $47.95 with a loss of -0.12% for the day. The stock had closed at $48.01 on the previous day. The total traded volume was 3,084,566 shares.

Also, UBS maintains its rating on Baxter International (NYSE:BAX). The global brokerage major raises the current price target from $48 per share to $50 per share. Analysts at the UBS have a current rating of Neutral on the shares. The rating by the firm was issued on July 28, 2016.

Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment, which include three commercial franchises: Hemophilia, BioTherapeutics and BioSurgery, and Medical Products segment, which include four commercial franchises: Fluid Systems, Renal, Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions, and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anesthetics. Its products are used in hospitals, kidney dialysis centers and nursing homes, among others.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.